Literature DB >> 17397892

Differences in tropism and pH dependence for glycoproteins from the Clade B1 arenaviruses: implications for receptor usage and pathogenicity.

Jill Oldenburg1, Therese Reignier, Meg L Flanagan, Genevieve A Hamilton, Paula M Cannon.   

Abstract

The Clade B lineage of the New World arenaviruses contains four viruses capable of causing severe hemorrhagic fevers in humans. Within this group, the B1 sub-lineage contains the pathogenic viruses Junin (JUNV) and Machupo (MACV), as well as the non-pathogenic Tacaribe virus (TCRV). In order to elucidate differences that may determine pathogenicity, we studied the entry pathways directed by the glycoproteins (GPs) from these related B1 viruses, using pseudotyped retroviral vectors and GP1 immunoadhesin constructs. Our data revealed variations in the efficiency with which different cell types could be transduced by B1 vectors, and this correlated with the ability of the immunoadhesins to bind to those cells. Interestingly, the tropism directed by the TCRV GP proved to be distinct from that of JUNV and MACV, in particular on lymphocyte cell lines. In addition, the GPs showed variations in their sensitivity to an inhibitor of endosome acidification, with the TCRV GP again being the outlier. Together these data suggest that more than one entry pathway can be used by these closely related viruses and that the ability to cause human disease may be highly dependent on receptor usage.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17397892      PMCID: PMC2743526          DOI: 10.1016/j.virol.2007.03.003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

Review 1.  Exotic emerging viral diseases: progress and challenges.

Authors:  Thomas W Geisbert; Peter B Jahrling
Journal:  Nat Med       Date:  2004-12       Impact factor: 53.440

2.  O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function.

Authors:  Mauro Imperiali; Claudio Thoma; Ernesto Pavoni; Andrea Brancaccio; Nico Callewaert; Annette Oxenius
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

3.  Receptor use by pathogenic arenaviruses.

Authors:  Therese Reignier; Jill Oldenburg; Beth Noble; Erika Lamb; Victor Romanowski; Michael J Buchmeier; Paula M Cannon
Journal:  Virology       Date:  2006-06-21       Impact factor: 3.616

4.  Identification of a cellular receptor for subgroup E avian leukosis virus.

Authors:  H B Adkins; J Brojatsch; J Naughton; M M Rolls; J M Pesola; J A Young
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

5.  The phylogeny of New World (Tacaribe complex) arenaviruses.

Authors:  M D Bowen; C J Peters; S T Nichol
Journal:  Virology       Date:  1996-05-01       Impact factor: 3.616

6.  Posttranslational modification of alpha-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding.

Authors:  Stefan Kunz; Jillian M Rojek; Motoi Kanagawa; Christina F Spiropoulou; Rita Barresi; Kevin P Campbell; Michael B A Oldstone
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

7.  Characterization of the cellular receptors for the South American hemorrhagic fever viruses Junin, Guanarito, and Machupo.

Authors:  Jillian M Rojek; Christina F Spiropoulou; Stefan Kunz
Journal:  Virology       Date:  2006-03-30       Impact factor: 3.616

8.  Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus.

Authors:  W Cao; M D Henry; P Borrow; H Yamada; J H Elder; E V Ravkov; S T Nichol; R W Compans; K P Campbell; M B Oldstone
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion.

Authors:  J S Kahn; M J Schnell; L Buonocore; J K Rose
Journal:  Virology       Date:  1999-02-01       Impact factor: 3.616

10.  Targeting of retroviral vectors through protease-substrate interactions.

Authors:  B H Nilson; F J Morling; F L Cosset; S J Russell
Journal:  Gene Ther       Date:  1996-04       Impact factor: 5.250

View more
  16 in total

1.  Substitutions in the glycoprotein (GP) of the Candid#1 vaccine strain of Junin virus increase dependence on human transferrin receptor 1 for entry and destabilize the metastable conformation of GP.

Authors:  Magali E Droniou-Bonzom; Therese Reignier; Jill E Oldenburg; Alex U Cox; Colin M Exline; Jessica Y Rathbun; Paula M Cannon
Journal:  J Virol       Date:  2011-10-05       Impact factor: 5.103

2.  Novel Arenavirus Entry Inhibitors Discovered by Using a Minigenome Rescue System for High-Throughput Drug Screening.

Authors:  Jessica Y Rathbun; Magali E Droniou; Robert Damoiseaux; Kevin G Haworth; Jill E Henley; Colin M Exline; Hyeryun Choe; Paula M Cannon
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

3.  Junin virus infects mouse cells and induces innate immune responses.

Authors:  Christian D Cuevas; Madakasira Lavanya; Enxiu Wang; Susan R Ross
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  Investigation of clade B New World arenavirus tropism by using chimeric GP1 proteins.

Authors:  Vanessa K Martin; Magali E Droniou-Bonzom; Therese Reignier; Jill E Oldenburg; Alex U Cox; Paula M Cannon
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

Review 5.  Drug discovery technologies and strategies for Machupo virus and other New World arenaviruses.

Authors:  Sheli R Radoshitzky; Jens H Kuhn; Fabian de Kok-Mercado; Peter B Jahrling; Sina Bavari
Journal:  Expert Opin Drug Discov       Date:  2012-05-19       Impact factor: 6.098

6.  Receptor use by the Whitewater Arroyo virus glycoprotein.

Authors:  Therese Reignier; Jill Oldenburg; Meg L Flanagan; Genevieve A Hamilton; Vanessa K Martin; Paula M Cannon
Journal:  Virology       Date:  2007-11-13       Impact factor: 3.616

7.  New world clade B arenaviruses can use transferrin receptor 1 (TfR1)-dependent and -independent entry pathways, and glycoproteins from human pathogenic strains are associated with the use of TfR1.

Authors:  Meg L Flanagan; Jill Oldenburg; Therese Reignier; Nathalia Holt; Genevieve A Hamilton; Vanessa K Martin; Paula M Cannon
Journal:  J Virol       Date:  2007-11-14       Impact factor: 5.103

8.  The RING domain and the L79 residue of Z protein are involved in both the rescue of nucleocapsids and the incorporation of glycoproteins into infectious chimeric arenavirus-like particles.

Authors:  Juan Cruz Casabona; Jesica M Levingston Macleod; Maria Eugenia Loureiro; Guillermo A Gomez; Nora Lopez
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

9.  Nonhuman transferrin receptor 1 is an efficient cell entry receptor for Ocozocoautla de Espinosa virus.

Authors:  Yíngyún Caì; Shuiqìng Yú; Steven Mazur; Lián Dong; Krisztina Janosko; Téngfei Zhang; Marcel A Müller; Lisa E Hensley; Sina Bavari; Peter B Jahrling; Sheli R Radoshitzky; Jens H Kuhn
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

10.  Host-species transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses.

Authors:  Jonathan Abraham; Jo Ann Kwong; César G Albariño; Jiajie G Lu; Sheli R Radoshitzky; Jorge Salazar-Bravo; Michael Farzan; Christina F Spiropoulou; Hyeryun Choe
Journal:  PLoS Pathog       Date:  2009-04-03       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.